Efficacy and safety of bivalirudin for percutaneous coronary intervention in acute coronary syndromes: a meta-analysis of randomized-controlled trials
ConclusionsCompared with heparin, bivalirudin was associated with a similar incidence of ischemic events following PCI for ACS. An association of bivalirudin with decreased bleeding was not seen with balanced use of GPI.
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research
More News: Angiomax | Angioplasty | Bleeding | Cardiology | Clinical Trials | Coronary Angioplasty | Databases & Libraries | Heart | Heart Attack | Ischemic Stroke | Percutaneous Coronary Intervention | Stroke | Thrombosis